Characterising the effects of exercise on immune cells in blood across the myeloma survivorship continuum

niversity of Bath0 个研究点目标入组 23 人开始时间: 2021年7月8日最近更新: 2024年6月24日

适应症

试验速览

暂无简介。

•1. A diagnosis of smouldering multiple myeloma who have not received any treatment.
•2. A diagnosis of multiple myeloma who have either: completed their first cycle of induction therapy, or are in remission following a successful haematopoietic stem cell transplant.
•3. Aged 18 years or over.

•1. World Health Organisation (WHO)/Eastern Cooperative Oncology Group (ECOG) performance status >1.
•2. Deemed unsafe to exercise according to the Physical Activity Readiness Questionnaire (PARQ).
•3. Any comorbidity that is likely to progress or be exacerbated over the course of the trial period.
•4. Cognitive impairment deemed a risk by the healthcare team or participation in the trials (e.g. diagnosis of neurodegenerative disease).
•5. Unable to understand explanations and/or provide informed consent.
•6. Any condition and/or behaviour that would pose undue personal risk or introduce bias into the trial.

发起方

niversity of Bath